Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-04

Clinical Trial Update: Treatment of CNS Sarcoidosis With H.P. Acthar Gel [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Acthar Gel for central nervous system sarcoidosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: CNS Sarcoidosis | Phase 4 | Status: COMPLETED | Results posted: 2021-02-04